{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:11:53Z","timestamp":1787170313560,"version":"build-2736575974"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00773","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T01:32:49Z","timestamp":1588210369000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["Thymic Function Associated With Cancer Development, Relapse, and Antitumor Immunity \u2013 A Mini-Review"],"prefix":"10.3389","volume":"11","author":[{"given":"Weikan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Sizova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ming","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00014","article-title":"Recent advances in targeting cd8 t-cell immunity for more effective cancer immunotherapy.","volume":"9","author":"Durgeau","year":"2018","journal-title":"Front Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1182\/blood.V96.2.384","article-title":"Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02836","article-title":"Harnessing NK cells for cancer treatment.","volume":"10","author":"Minetto","year":"2019","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","article-title":"The biology and functional importance of MAIT cells.","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrc3670","article-title":"Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.","volume":"14","author":"Coulie","year":"2014","journal-title":"Nat Rev Cancer."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3249","article-title":"Investigation of antigen-specific T-cell receptor clusters in human cancers.","volume":"26","author":"Zhang","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting.","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review.","volume":"234","author":"Farhood","year":"2019","journal-title":"J Cell Physiol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00219","article-title":"Cognate interaction with CD4(+) T cells instructs tumor-associated macrophages to acquire M1-like phenotype.","volume":"10","author":"Eisel","year":"2019","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.coi.2009.12.006","article-title":"Alphabeta versus gammadelta lineage choice at the first TCR-controlled checkpoint.","volume":"22","author":"Kreslavsky","year":"2010","journal-title":"Curr Opin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ni1216","article-title":"Notch signaling controls the generation and differentiation of early T lineage progenitors.","volume":"6","author":"Sambandam","year":"2005","journal-title":"Nat Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1101\/gad.327163.119","article-title":"Programming for T-lymphocyte fates: modularity and mechanisms.","volume":"33","author":"Rothenberg","year":"2019","journal-title":"Genes Dev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev-cellbio-092910-154008","article-title":"Mechanisms of T cell development and transformation.","volume":"27","author":"Koch","year":"2011","journal-title":"Annu Rev Cell Dev Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ni.3122","article-title":"IL-7 coordinates proliferation, differentiation and Tcra recombination during thymocyte beta-selection.","volume":"16","author":"Boudil","year":"2015","journal-title":"Nat Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nrc2250","article-title":"Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy.","volume":"7","author":"Colombo","year":"2007","journal-title":"Nat Rev Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxw025","article-title":"Roles of regulatory T cells in cancer immunity.","volume":"28","author":"Takeuchi","year":"2016","journal-title":"Int Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-018-0083-6","article-title":"Central CD4(+) T cell tolerance: deletion versus regulatory T cell differentiation.","volume":"19","author":"Klein","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.1073\/pnas.0601040103","article-title":"Thymic output in aged mice.","volume":"103","author":"Hale","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1034\/j.1600-065x.2002.18902.x","article-title":"Role of thymic organ structure and stromal composition in steady-state postnatal T-cell production.","volume":"189","author":"Petrie","year":"2002","journal-title":"Immunol Rev."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2003352","article-title":"Capacity of tTreg generation is not impaired in the atrophied thymus.","volume":"15","author":"Oh","year":"2017","journal-title":"PLoS Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/ni.1874","article-title":"Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance.","volume":"11","author":"Hinterberger","year":"2010","journal-title":"Nat Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.20131889","article-title":"Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance.","volume":"211","author":"Khan","year":"2014","journal-title":"J Exp Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1158\/0008-5472.CAN-12-3781","article-title":"Aire deficiency promotes TRP-1-specific immune rejection of melanoma.","volume":"73","author":"Zhu","year":"2013","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.950169","article-title":"Breaking through the central tolerance ceiling to unleash anticancer immune responses.","volume":"3","author":"Su","year":"2014","journal-title":"Oncoimmunology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.coi.2012.04.005","article-title":"Homeostasis and function of regulatory T cells in aging.","volume":"24","author":"Raynor","year":"2012","journal-title":"Curr Opin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4049\/jimmunol.1001505","article-title":"A major role for Bim in regulatory T cell homeostasis.","volume":"186","author":"Chougnet","year":"2011","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10549-011-1647-3","article-title":"CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.","volume":"130","author":"Liu","year":"2011","journal-title":"Breast Cancer Res Treat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.coi.2008.04.008","article-title":"Regulatory T cells and treatment of cancer.","volume":"20","author":"Curiel","year":"2008","journal-title":"Curr Opin Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","article-title":"Age and cancer risk: a potentially modifiable relationship.","author":"White","year":"2014","journal-title":"Am J Prev Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000353350","article-title":"Disruption of the thymic microenvironment is associated with thymic involution of transitional cell cancer.","volume":"92","author":"Song","year":"2014","journal-title":"Urol Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3892\/ijo.2010.870","article-title":"Tumor-induced thymic atrophy: alteration in interferons and Jak\/Stats signaling pathways.","volume":"38","author":"Carrio","year":"2011","journal-title":"Int J Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1016\/j.lfs.2005.05.038","article-title":"Failure in peripheral immuno-surveillance due to thymic atrophy: importance of thymocyte maturation and apoptosis in adult tumor-bearer.","volume":"77","author":"Mandal","year":"2005","journal-title":"Life Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/bf02700019","article-title":"Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression.","volume":"64","author":"Prins","year":"2003","journal-title":"J Neurooncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/a:1020356020542","article-title":"Influence of breast cancer on thymic function in mice.","volume":"7","author":"Lopez","year":"2002","journal-title":"J Mammary Gland Biol Neoplasia."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1182\/blood-2002-07-1956","article-title":"VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.","volume":"101","author":"Ohm","year":"2003","journal-title":"Blood."},{"key":"B36","first-page":"91","article-title":"Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing mice.","volume":"22","author":"Sun","year":"2002","journal-title":"Anticancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1158\/1541-7786.MCR-18-0308","article-title":"Atrophied thymus, a tumor reservoir for harboring melanoma cells.","volume":"16","author":"Sizova","year":"2018","journal-title":"Mol Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2010.09.043","article-title":"DNA damage-mediated induction of a chemoresistant niche.","volume":"143","author":"Gilbert","year":"2010","journal-title":"Cell."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1101\/gad.284851.116","article-title":"A senescence secretory switch mediated by PI3K\/AKT\/mTOR activation controls chemoprotective endothelial secretory responses.","volume":"30","author":"Bent","year":"2016","journal-title":"Genes Dev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors.","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest."},{"key":"B41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ccell.2015.03.007","article-title":"The journey from discoveries in fundamental immunology to cancer immunotherapy.","volume":"27","author":"Miller","year":"2015","journal-title":"Cancer Cell."},{"key":"B42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ni1033","article-title":"Age-related changes in lymphocyte development and function.","volume":"5","author":"Linton","year":"2004","journal-title":"Nat Immunol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-0173-8","article-title":"Contributions of age-related thymic involution to immunosenescence and inflammaging.","volume":"17","author":"Thomas","year":"2020","journal-title":"Immun Ageing."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","article-title":"Age and immunity: What is \u201cimmunosenescence\u201d?","volume":"105","author":"Pawelec","year":"2018","journal-title":"Exp Gerontol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-018-0082-9","article-title":"The impact of senescence-associated T cells on immunosenescence and age-related disorders.","volume":"38","author":"Fukushima","year":"2018","journal-title":"Inflamm Regen."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?","volume":"8","author":"Fulop","year":"2017","journal-title":"Front Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00281-018-0697-6","article-title":"Does patient age influence anti-cancer immunity?","volume":"41","author":"Pawelec","year":"2019","journal-title":"Semin Immunopathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cei.12875","article-title":"Considerations for successful cancer immunotherapy in aged hosts.","volume":"187","author":"Hurez","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1158\/2326-6066.CIR-19-0567","article-title":"Impact of TCR diversity on the development of transplanted or chemically induced tumors.","volume":"8","author":"Schreiber","year":"2020","journal-title":"Cancer Immunol Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1073\/pnas.1714478115","article-title":"Thymic involution and rising disease incidence with age.","volume":"115","author":"Palmer","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"15807","DOI":"10.1073\/pnas.0908805106","article-title":"PD-1+ memory phenotype CD4+ T cells expressing C\/EBPalpha underlie T cell immunodepression in senescence and leukemia.","volume":"106","author":"Shimatani","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.4049\/jimmunol.1500319","article-title":"A CD153+CD4+ T follicular cell population with cell-senescence features plays a crucial role in lupus pathogenesis via osteopontin production.","volume":"194","author":"Tahir","year":"2015","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4049\/jimmunol.1602005","article-title":"Physiologic thymic involution underlies age-dependent accumulation of senescence-associated CD4(+) T Cells.","volume":"199","author":"Sato","year":"2017","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","article-title":"CD28(-) T cells: their role in the age-associated decline of immune function.","volume":"30","author":"Weng","year":"2009","journal-title":"Trends Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.0105-2896.2005.00256.x","article-title":"CD28 extinction in human T cells: altered functions and the program of T-cell senescence.","volume":"205","author":"Vallejo","year":"2005","journal-title":"Immunol Rev."},{"key":"B56","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.4049\/jimmunol.152.8.3740","article-title":"Aged T cells are hyporesponsive to costimulation mediated by CD28.","volume":"152","author":"Engwerda","year":"1994","journal-title":"J Immunol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12675","article-title":"Human CD8(+) EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK.","volume":"17","author":"Callender","year":"2018","journal-title":"Aging Cell."},{"key":"B58","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy.","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0629-x","article-title":"T cell senescence and CAR-T cell exhaustion in hematological malignancies.","volume":"11","author":"Kasakovski","year":"2018","journal-title":"J Hematol Oncol."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00386","article-title":"Tumor-Intrinsic PD-L1 signaling in cancer initiation, development and treatment: beyond immune evasion.","volume":"8","author":"Dong","year":"2018","journal-title":"Front Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway.","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","article-title":"The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity.","volume":"193","author":"Ostrand-Rosenberg","year":"2014","journal-title":"J Immunol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa006","article-title":"Physiology and pathology of T-cell aging.","author":"Minato","year":"","journal-title":"Int Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01701","article-title":"Antigen-specificity in the thymic development and peripheral activity of cd4(+)foxp3(+) t regulatory cells.","volume":"9","author":"Pohar","year":"2018","journal-title":"Front Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/icb.2010.123","article-title":"Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes.","volume":"89","author":"Wirnsberger","year":"2011","journal-title":"Immunol Cell Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.4049\/jimmunol.1500082","article-title":"Thymic involution perturbs negative selection leading to autoreactive T cells that induce chronic inflammation.","volume":"194","author":"Coder","year":"2015","journal-title":"J Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/acel.12191","article-title":"Aging is associated with increased regulatory T-cell function.","volume":"13","author":"Garg","year":"2014","journal-title":"Aging Cell."},{"key":"B68","doi-asserted-by":"publisher","first-page":"23058","DOI":"10.18632\/oncotarget.5492","article-title":"Regulation of bim in health and disease.","volume":"6","author":"Sionov","year":"2015","journal-title":"Oncotarget."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000492","article-title":"Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.","volume":"5","author":"Paschos","year":"2009","journal-title":"PLoS Pathog."},{"key":"B70","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nri2570","article-title":"CD95, BIM and T cell homeostasis.","volume":"9","author":"Bouillet","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"18333","DOI":"10.1073\/pnas.0910139106","article-title":"Age-associated increase in lifespan of naive CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects.","volume":"106","author":"Tsukamoto","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B72","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.4049\/jimmunol.1001668","article-title":"Bim dictates naive CD4 T cell lifespan and the development of age-associated functional defects.","volume":"185","author":"Tsukamoto","year":"2010","journal-title":"J Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1172\/JCI28941","article-title":"Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.","volume":"116","author":"Vukmanovic-Stejic","year":"2006","journal-title":"J Clin Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2249.2005.02798.x","article-title":"The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age.","volume":"140","author":"Gregg","year":"2005","journal-title":"Clin Exp Immunol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00231","article-title":"The impact of aging on regulatory T-cells.","volume":"4","author":"Fessler","year":"2013","journal-title":"Front Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.08.007","article-title":"A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.","volume":"95","author":"Kumar","year":"2018","journal-title":"J Autoimmun."},{"key":"B77","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semcancer.2005.11.005","article-title":"Regulatory T cells in immune surveillance and treatment of cancer.","volume":"16","author":"Yamaguchi","year":"2006","journal-title":"Semin Cancer Biol."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00680","article-title":"The pivotal role of regulatory T cells in the regulation of innate immune cells.","volume":"10","author":"Okeke","year":"2019","journal-title":"Front Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/jcp.25016","article-title":"Treg(s) in cancer: friends or foe?","volume":"230","author":"Wolf","year":"2015","journal-title":"J Cell Physiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","article-title":"Regulatory T cells and cancer.","volume":"19","author":"Wang","year":"2007","journal-title":"Curr Opin Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.20041130","article-title":"Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.","volume":"200","author":"Turk","year":"2004","journal-title":"J Exp Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity.","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int J Cancer."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.18632\/aging.101918","article-title":"Epigenetic control of Foxp3 in intratumoral T-cells regulates growth of hepatocellular carcinoma.","volume":"11","author":"Liu","year":"2019","journal-title":"Aging (Albany NY)."},{"key":"B84","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1517\/14712598.2014.900539","article-title":"Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.","volume":"14","author":"Chaudhary","year":"2014","journal-title":"Expert Opin Biol Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20041959","article-title":"Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.","volume":"201","author":"Nishikawa","year":"2005","journal-title":"J Exp Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"14571","DOI":"10.1073\/pnas.251547298","article-title":"Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.","volume":"98","author":"Nishikawa","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1126\/science.1233913","article-title":"Aire-dependent thymic development of tumor-associated regulatory T cells.","volume":"339","author":"Malchow","year":"2013","journal-title":"Science."},{"key":"B88","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1158\/0008-5472.CAN-10-1797","article-title":"Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.","volume":"71","author":"Hindley","year":"2011","journal-title":"Cancer Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/neuonc\/nor134","article-title":"Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.","volume":"13","author":"Wainwright","year":"2011","journal-title":"Neuro Oncol."},{"key":"B90","first-page":"3128","article-title":"Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.","volume":"59","author":"Onizuka","year":"1999","journal-title":"Cancer Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1172\/JCI128672","article-title":"A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target.","volume":"130","author":"Freeman","year":"2020","journal-title":"J Clin Invest."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/sj.bjc.6603824","article-title":"The impact of regulatory T cells on carcinogen-induced sarcogenesis.","volume":"96","author":"Betts","year":"2007","journal-title":"Br J Cancer."},{"key":"B93","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.192.2.303","article-title":"Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.","volume":"192","author":"Takahashi","year":"2000","journal-title":"J Exp Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1084\/jem.20050940","article-title":"Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.","volume":"202","author":"Ko","year":"2005","journal-title":"J Exp Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1113401","article-title":"Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.","volume":"309","author":"Peng","year":"2005","journal-title":"Science."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1182\/blood-2004-07-2959","article-title":"Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.","volume":"105","author":"Valzasina","year":"2005","journal-title":"Blood."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade.","volume":"271","author":"Leach","year":"1996","journal-title":"Science."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and Anti-CTLA-4 therapies in cancer: mechanisms of action. Efficacy, and limitations.","volume":"8","author":"Seidel","year":"2018","journal-title":"Front Oncol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","article-title":"Mechanisms governing metastatic dormancy and reactivation.","volume":"155","author":"Giancotti","year":"2013","journal-title":"Cell."},{"key":"B101","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","article-title":"Models, mechanisms and clinical evidence for cancer dormancy.","volume":"7","author":"Aguirre-Ghiso","year":"2007","journal-title":"Nat Rev Cancer."},{"key":"B102","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrc1370","article-title":"Dissecting the metastatic cascade.","volume":"4","author":"Pantel","year":"2004","journal-title":"Nat Rev Cancer."},{"key":"B103","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges.","volume":"12","author":"Steeg","year":"2006","journal-title":"Nat Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006.","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin."},{"key":"B105","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy.","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat Cell Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10195-015-0344-0","article-title":"Bone metastases of unknown origin: epidemiology and principles of management.","volume":"16","author":"Piccioli","year":"2015","journal-title":"J Orthop Traumatol."},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2015.57","article-title":"Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors.","volume":"4","author":"Shiozawa","year":"2015","journal-title":"Bonekey Rep."},{"key":"B108","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.1158\/0008-5472.CAN-13-0991","article-title":"A novel model of dormancy for bone metastatic breast cancer cells.","volume":"73","author":"Marlow","year":"2013","journal-title":"Cancer Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molmed.2010.07.001","article-title":"Circulating tumour cells in cancer patients: challenges and perspectives.","volume":"16","author":"Pantel","year":"2010","journal-title":"Trends Mol Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-med-062310-094219","article-title":"Circulating tumor cells and circulating tumor DNA.","volume":"63","author":"Alix-Panabieres","year":"2012","journal-title":"Annu Rev Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrc3773","article-title":"Inside and out: the activities of senescence in cancer.","volume":"14","author":"Perez-Mancera","year":"2014","journal-title":"Nat Rev Cancer."},{"key":"B112","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","article-title":"Microenvironmental regulation of therapeutic response in cancer.","volume":"25","author":"Klemm","year":"2015","journal-title":"Trends Cell Biol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1158\/1078-0432.CCR-13-0897","article-title":"Molecular pathways: niches in metastatic dormancy.","volume":"20","author":"Yumoto","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2890","article-title":"Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.","volume":"18","author":"Sun","year":"2012","journal-title":"Nat Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gde.2010.10.011","article-title":"Framework models of tumor dormancy from patient-derived observations.","volume":"21","author":"Klein","year":"2011","journal-title":"Curr Opin Genet Dev."},{"key":"B116","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nature06309","article-title":"Adaptive immunity maintains occult cancer in an equilibrium state.","volume":"450","author":"Koebel","year":"2007","journal-title":"Nature."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1158\/0008-5472.CAN-13-2084","article-title":"T lymphocytes restrain spontaneous metastases in permanent dormancy.","volume":"74","author":"Romero","year":"2014","journal-title":"Cancer Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.urolonc.2003.12.012","article-title":"ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).","volume":"63","author":"Aguirre-Ghiso","year":"2003","journal-title":"Cancer Res."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2013.320","article-title":"Tumour dormancy and clinical implications in breast cancer.","volume":"7","author":"Gelao","year":"2013","journal-title":"Ecancermedicalscience."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4161\/onci.24898","article-title":"Organ-specific regulatory T cells of thymic origin are expanded in murine prostate tumors.","volume":"2","author":"Malchow","year":"2013","journal-title":"Oncoimmunology."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93265","article-title":"Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity.","volume":"2","author":"Bakhru","year":"2017","journal-title":"JCI Insight."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035005","article-title":"The immune response to melanoma is limited by thymic selection of self-antigens.","volume":"7","author":"Trager","year":"2012","journal-title":"PLoS One."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/ni723","article-title":"Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.","volume":"2","author":"Derbinski","year":"2001","journal-title":"Nat Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1158\/2326-6066.cir-18-0912","article-title":"Pulling RANK on cancer: blocking aire-mediated central tolerance to enhance immunotherapy.","volume":"7","author":"Su","year":"2019","journal-title":"Cancer Immunol Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1084\/jem.20070795","article-title":"Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire.","volume":"204","author":"Gray","year":"2007","journal-title":"J Exp Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1182\/blood-2006-02-004531","article-title":"Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells.","volume":"108","author":"Gray","year":"2006","journal-title":"Blood."},{"key":"B128","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cell.2015.10.013","article-title":"Fezf2 orchestrates a thymic program of self-antigen expression for immune tolerance.","volume":"163","author":"Takaba","year":"2015","journal-title":"Cell."},{"key":"B129","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12026-012-8301-y","article-title":"Thymic epithelial cells: antigen presenting cells that regulate T cell repertoire and tolerance development.","volume":"54","author":"Alexandropoulos","year":"2012","journal-title":"Immunol Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/imm.12387","article-title":"Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy.","volume":"144","author":"Karimi","year":"2015","journal-title":"Immunology."},{"key":"B131","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1034\/j.1600-065x.2002.18811.x","article-title":"Multiple pathways to tumor immunity and concomitant autoimmunity.","volume":"188","author":"Turk","year":"2002","journal-title":"Immunol Rev."},{"key":"B132","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrendo.2010.200","article-title":"The role of AIRE in human autoimmune disease.","volume":"7","author":"Akirav","year":"2011","journal-title":"Nat Rev Endocrinol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science."},{"key":"B134","doi-asserted-by":"publisher","first-page":"41641","DOI":"10.18632\/oncotarget.16335","article-title":"Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.","volume":"8","author":"Franzese","year":"2017","journal-title":"Oncotarget."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00316","article-title":"The effect of age on thymic function.","volume":"4","author":"Palmer","year":"2013","journal-title":"Front Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1172\/JCI86800","article-title":"Estrogen turns down \u201cthe AIRE\u201d.","volume":"126","author":"Bakhru","year":"2016","journal-title":"J Clin Invest."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1172\/JCI81894","article-title":"Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.","volume":"126","author":"Dragin","year":"2016","journal-title":"J Clin Invest."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T09:29:46Z","timestamp":1696066186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":137,"alternative-id":["10.3389\/fimmu.2020.00773"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00773","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"article-number":"773"}}